HROW vs LSI
Harrow Health Inc (HROW) versus LSI (LSI) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
LSI (LSI) common stock.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
LSI does not have a complete income-statement cache yet.
HROW currently screens at market cap $1.28B.
Not investment advice. Open the HROW and LSI stock pages for the full models.
Not investment advice.